Frontotemporal dementia (FTD) is one of the most common causes of progressive dementia in working-age people. However, making a diagnosis and a prognosis is often…
A new highly selective PET imaging agent can detect the presence of overexpressed monoamine oxidase-B (MAO-B) in cognitively unimpaired individuals with high beta amyloid (Ab)—one…
Phosphodiesterase-5 (PDE5) inhibitors seem not to be associated with a reduced risk for Alzheimer disease and related dementia, according to a study published online Oct.…
A new study from Karolinska Institutet and the Karolinska University Hospital indicates that only a rather small proportion of individuals attending a specialized memory clinic…
Alzheimer’s disease (AD) currently has no cure and is predicted to affect over 100 million people worldwide by 2050. Ongoing research is focused on two…
Depression has long been associated with an increased risk of dementia, and now a new study provides evidence that timely treatment of depression could lower…
UVA Health researchers have discovered a molecule in the brain responsible for orchestrating the immune system’s responses to Alzheimer’s disease and multiple sclerosis (MS), potentially…
At 53, Michele Hall was at the height of her legal career. She’d just sent her three kids to college. She had decades ahead with…
Partner companies Eisai and Biogen recently announced promising clinical trial results for their new Alzheimer’s drug lecanemab. Over 18 months, patients treated with lecanemab experienced…
People living with dementia may benefit from talking therapies available on the NHS, if they suffer from anxiety or depression, finds a new study led…